Literature DB >> 16463353

MR spectroscopic evidence for thalamic and hippocampal, but not cortical, damage in multiple sclerosis.

Jeroen J G Geurts1, Ilona E W Reuling, Hugo Vrenken, Bernard M J Uitdehaag, Chris H Polman, Jonas A Castelijns, Frederik Barkhof, Petra J W Pouwels.   

Abstract

Gray matter (GM) damage is an important pathophysiological feature in Multiple Sclerosis (MS), and may be related to clinical, including cognitive, deficits. Quantitative single-voxel (1)H-Magnetic Resonance Spectroscopy (TR/TE 6000/20 ms) was performed in 33 MS patients (11 per disease subtype; mean age 48 years, 16 females) and 10 healthy controls (mean age 43 years, 7 females). No overall spectroscopic changes were found in MS cortex. In MS thalamus, a 9% decrease of N-acetyl aspartate (NAA; P=0.005) and a 31% increase of myo-inositol (Ins; P=0.002) were found. A 21% Ins increase was observed (P=0.02) in MS hippocampus. Reduced NAA and increased Ins concentrations are thought to reflect neuro-axonal damage or loss and gliosis, respectively. Significant correlations between Ins concentrations and total-brain T(2) lesion load were found for MS thalamus (r=0.65, P<0.001) and hippocampus (r=0.57, P=0.001). MS thalamic and hippocampal Ins concentrations also correlated with each other (r=0.68; P<0.001). Cortical Gln correlated with thalamic NAA (r=-0.38; P=0.03) in MS. Thalamic and hippocampal Ins increases were most prominent in secondary-progressive (SP) patients (37% and 34%, respectively), whereas the largest thalamic NAA decrease (14%) was found in primary-progressive (PP) patients. In conclusion, thalamic and hippocampal GM pathology are important features of (progressive) MS. Magn Reson Med, 2006. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16463353     DOI: 10.1002/mrm.20792

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  32 in total

1.  Smaller cornu ammonis 2-3/dentate gyrus volumes and elevated cortisol in multiple sclerosis patients with depressive symptoms.

Authors:  Stefan M Gold; Kyle C Kern; Mary-Frances O'Connor; Michael J Montag; Aileen Kim; Ye S Yoo; Barbara S Giesser; Nancy L Sicotte
Journal:  Biol Psychiatry       Date:  2010-06-19       Impact factor: 13.382

2.  Improved identification of intracortical lesions in multiple sclerosis with phase-sensitive inversion recovery in combination with fast double inversion recovery MR imaging.

Authors:  F Nelson; A H Poonawalla; P Hou; F Huang; J S Wolinsky; P A Narayana
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-20       Impact factor: 3.825

Review 3.  MR imaging of gray matter involvement in multiple sclerosis: implications for understanding disease pathophysiology and monitoring treatment efficacy.

Authors:  Massimo Filippi; M A Rocca
Journal:  AJNR Am J Neuroradiol       Date:  2009-12-31       Impact factor: 3.825

4.  Evidencing different neurochemical profiles between thalamic nuclei using high resolution 2D-PRESS semi-LASER (1)H-MRSI at 7 T.

Authors:  Maxime Donadieu; Yann Le Fur; Sylviane Confort-Gouny; Arnaud Le Troter; Maxime Guye; Jean-Philippe Ranjeva
Journal:  MAGMA       Date:  2016-04-08       Impact factor: 2.310

5.  Fully automated atlas-based method for prescribing 3D PRESS MR spectroscopic imaging: Toward robust and reproducible metabolite measurements in human brain.

Authors:  Wei Bian; Yan Li; Jason C Crane; Sarah J Nelson
Journal:  Magn Reson Med       Date:  2017-05-03       Impact factor: 4.668

6.  Glutamate-sensitive imaging and evaluation of cognitive impairment in multiple sclerosis.

Authors:  Kristin P O'Grady; Adrienne N Dula; Bailey D Lyttle; Lindsey M Thompson; Benjamin N Conrad; Bailey A Box; Lydia J McKeithan; Siddharama Pawate; Francesca Bagnato; Bennett A Landman; Paul Newhouse; Seth A Smith
Journal:  Mult Scler       Date:  2018-09-19       Impact factor: 6.312

Review 7.  Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain.

Authors:  Linda Chang; Sody M Munsaka; Stephanie Kraft-Terry; Thomas Ernst
Journal:  J Neuroimmune Pharmacol       Date:  2013-05-12       Impact factor: 4.147

8.  Metabolic voxel-based analysis of the complete human brain using fast 3D-MRSI: Proof of concept in multiple sclerosis.

Authors:  Maxime Donadieu; Yann Le Fur; Angèle Lecocq; Andrew A Maudsley; Soraya Gherib; Elisabeth Soulier; Sylviane Confort-Gouny; Fanelly Pariollaud; Marie-Pierre Ranjeva; Jean Pelletier; Maxime Guye; Wafaa Zaaraoui; Bertrand Audoin; Jean-Philippe Ranjeva
Journal:  J Magn Reson Imaging       Date:  2016-01-12       Impact factor: 4.813

9.  Thalamic lesions in multiple sclerosis by 7T MRI: Clinical implications and relationship to cortical pathology.

Authors:  Daniel M Harrison; Jiwon Oh; Snehashis Roy; Emily T Wood; Anna Whetstone; Michaela A Seigo; Craig K Jones; Dzung Pham; Peter van Zijl; Daniel S Reich; Peter A Calabresi
Journal:  Mult Scler       Date:  2015-01-12       Impact factor: 6.312

10.  Detection of altered hippocampal morphology in multiple sclerosis-associated depression using automated surface mesh modeling.

Authors:  Stefan M Gold; Mary-Frances O'Connor; Raja Gill; Kyle C Kern; Yonggang Shi; Roland G Henry; Daniel Pelletier; David C Mohr; Nancy L Sicotte
Journal:  Hum Brain Mapp       Date:  2012-07-30       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.